-
Something wrong with this record ?
SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis
M. Castorálová, D. Březinová, M. Svéda, J. Lipov, T. Ruml, Z. Knejzlík,
Language English Country Netherlands
Document type Journal Article
- MeSH
- Benzoquinones pharmacology MeSH
- Models, Biological MeSH
- Cycloheximide pharmacology MeSH
- HEK293 Cells MeSH
- HeLa Cells MeSH
- Protein Synthesis Inhibitors pharmacology MeSH
- Leupeptins pharmacology MeSH
- Humans MeSH
- Lactams, Macrocyclic pharmacology MeSH
- Small Ubiquitin-Related Modifier Proteins metabolism MeSH
- Proteasome Endopeptidase Complex metabolism MeSH
- Protein Biosynthesis drug effects MeSH
- Puromycin pharmacology MeSH
- Heat-Shock Response drug effects MeSH
- Sumoylation drug effects MeSH
- Ubiquitins metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Small ubiquitin-related modifiers 1, 2 and 3 (SUMO-1, -2, -3), members of the ubiquitin-like protein family, can be conjugated to various cellular proteins. Conjugates of SUMO-2 and SUMO-3 (SUMO-2/3) accumulate in cells exposed to various stress stimuli or to MG132 treatment. Although the proteins modified by SUMO-2/3 during heat shock or under MG132 treatment have been identified, the significance of this modification remains unclear. Our data show that the inhibition of translation by puromycin or cycloheximide blocks both the heat shock and MG132 induced accumulation of SUMO-2/3 conjugates in HEK 293T and U2OS cells. However, the heat shock induced accumulation of SUMO-2/3 conjugates was restored by proteasome inhibition, which suggests that the inhibition of translation did not abolish SUMOylation itself. Furthermore, we show that some of the proteins truncated due to the treatment by low concentration of puromycin are SUMOylated in HEK 293T cells. We suggest that the SUMO-2/3 conjugates accumulating under the heat shock or MG132 treatment result largely from new protein synthesis and that portion of them is incorrectly folded.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000956
- 003
- CZ-PrNML
- 005
- 20250121111715.0
- 007
- ta
- 008
- 130108s2012 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbamcr.2012.01.010 $2 doi
- 035 __
- $a (PubMed)22306003
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Castorálová, Markéta $u Department of Biochemistry, Institute of Chemical Technology, Prague, Czech Republic.
- 245 10
- $a SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis / $c M. Castorálová, D. Březinová, M. Svéda, J. Lipov, T. Ruml, Z. Knejzlík,
- 520 9_
- $a Small ubiquitin-related modifiers 1, 2 and 3 (SUMO-1, -2, -3), members of the ubiquitin-like protein family, can be conjugated to various cellular proteins. Conjugates of SUMO-2 and SUMO-3 (SUMO-2/3) accumulate in cells exposed to various stress stimuli or to MG132 treatment. Although the proteins modified by SUMO-2/3 during heat shock or under MG132 treatment have been identified, the significance of this modification remains unclear. Our data show that the inhibition of translation by puromycin or cycloheximide blocks both the heat shock and MG132 induced accumulation of SUMO-2/3 conjugates in HEK 293T and U2OS cells. However, the heat shock induced accumulation of SUMO-2/3 conjugates was restored by proteasome inhibition, which suggests that the inhibition of translation did not abolish SUMOylation itself. Furthermore, we show that some of the proteins truncated due to the treatment by low concentration of puromycin are SUMOylated in HEK 293T cells. We suggest that the SUMO-2/3 conjugates accumulating under the heat shock or MG132 treatment result largely from new protein synthesis and that portion of them is incorrectly folded.
- 650 _2
- $a benzochinony $x farmakologie $7 D016227
- 650 _2
- $a cykloheximid $x farmakologie $7 D003513
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a reakce na tepelný šok $x účinky léků $7 D018869
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a makrocyklické laktamy $x farmakologie $7 D047029
- 650 _2
- $a leupeptiny $x farmakologie $7 D007976
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a proteasomový endopeptidasový komplex $x metabolismus $7 D046988
- 650 _2
- $a proteosyntéza $x účinky léků $7 D014176
- 650 _2
- $a inhibitory syntézy proteinů $x farmakologie $7 D011500
- 650 _2
- $a puromycin $x farmakologie $7 D011691
- 650 _2
- $a malé modifikační proteiny související s ubikvitinem $x metabolismus $7 D025841
- 650 _2
- $a sumoylace $x účinky léků $7 D058207
- 650 _2
- $a ubikvitiny $x metabolismus $7 D014452
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Březinová, Dagmar $7 xx0327825
- 700 1_
- $a Svéda, Martin
- 700 1_
- $a Lipov, Jan
- 700 1_
- $a Ruml, Tomáš
- 700 1_
- $a Knejzlík, Zdeněk, $d 1975- $7 mzk2007385868
- 773 0_
- $w MED00009314 $t Biochimica et biophysica acta $x 0006-3002 $g Roč. 1823, č. 4 (2012), s. 911-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22306003 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20250121111712 $b ABA008
- 999 __
- $a ok $b bmc $g 963738 $s 799120
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 1823 $c 4 $d 911-9 $i 0006-3002 $m Biochimica et biophysica acta $n Biochim Biophys Acta $x MED00009314
- LZP __
- $a Pubmed-20130108